Cardiovascular
At Johnson & Johnson, we take on the most pervasive diseases that burden hundreds of millions of people and healthcare systems around the world. As part of this long-standing commitment and propelled by our successes in treating thrombosis, we advance highly differentiated therapies that prevent and treat life-threatening cardiovascular diseases. The prevalence of these diseases is growing, straining patients, their families and healthcare systems. Uncovering new therapies that have the potential to improve the lives of this large segment of the population is an important endeavor—one which we will continue to lead in the years to come. Our relentless pursuit of innovation means patients get the treatments they need as fast as possible.
Expand
Collapse
Our vision is to improve the lives of the millions of people living with cardiovascular diseases and to work tirelessly to eliminate them.
Focus areas
Our robust pipeline spans multiple focus areas with a number of programs in development, as well as select novel therapy programs recently approved, or with potential filings in the United States/European Union.
Our one team philosophy guides us and our partners toward a shared vision: eliminating cardiovascular diseases so all people can lead happier, healthier, longer lives.
We offer resources and programs to inform and educate patients, families, communities and the physicians who care for them about cardiovascular diseases.
Related links